Clark Capital Management Group, Inc. Astrazeneca PLC Transaction History
Clark Capital Management Group, Inc.
- $15.2 Billion
- Q3 2025
A detailed history of Clark Capital Management Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 1,294,484 shares of AZN stock, worth $116 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
1,294,484
Previous 666,513
94.22%
Holding current value
$116 Million
Previous $46.6 Million
113.23%
% of portfolio
0.65%
Previous 0.34%
Shares
20 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...